Clinical Trials Browser

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT07622407 2026-06-03

TIMELY REHAB

Ototoxicity, Deglutition Disorders, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Tinnitus, Hearing Loss, Drug-Related Side Effects and Adverse Reactions

Clinical Trials

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

TIMELY REHAB